# Celestica Inc: overview

CLS · NYSE · CIK 1030894 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cls.md) · [Financials](/companies/cls/financials.md) · [Filings](/companies/cls/filings.md) · [Insiders](/companies/cls/insiders.md)

Latest reported revenue: [$5.83bn](/filings/0001030894-26-000050.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 26, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001030894-26-000050).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,546 d](/filings/0001030894-26-000011.md) | [2,649](/filings/0001030894-26-000032.md) | [2,893](/filings/0001030894-26-000044.md) | [3,194](/filings/0001030894-26-000050.md) | [3,655 d](/filings/0001030894-26-000011.md) | [4,047](/filings/0001030894-26-000032.md) | [4,699](/filings/0001030894-26-000044.md) | [5,830](/filings/0001030894-26-000050.md) |
| Gross margin | % | [11.7% d](/filings/0001030894-26-000011.md) | [10.3%](/filings/0001030894-26-000032.md) | [12.8%](/filings/0001030894-26-000044.md) | [13.0%](/filings/0001030894-26-000050.md) | [11.8% d](/filings/0001030894-26-000011.md) | [10.8%](/filings/0001030894-26-000032.md) | [12.3%](/filings/0001030894-26-000044.md) | [11.0%](/filings/0001030894-26-000050.md) |
| Operating margin | % | [8.0% d](/filings/0001030894-26-000011.md) | [4.9%](/filings/0001030894-26-000032.md) | [9.4%](/filings/0001030894-26-000044.md) | [10.2%](/filings/0001030894-26-000050.md) | [8.6% d](/filings/0001030894-26-000011.md) | [6.7%](/filings/0001030894-26-000032.md) | [9.8%](/filings/0001030894-26-000044.md) | [7.9%](/filings/0001030894-26-000050.md) |
| Net margin | % | [6.0% d](/filings/0001030894-26-000011.md) | [3.3%](/filings/0001030894-26-000032.md) | [7.3%](/filings/0001030894-26-000044.md) | [8.4%](/filings/0001030894-26-000050.md) | [7.3% d](/filings/0001030894-26-000011.md) | [5.2%](/filings/0001030894-26-000032.md) | [7.8%](/filings/0001030894-26-000044.md) | [6.8%](/filings/0001030894-26-000050.md) |
| Diluted EPS | $ per share | not reported | [0.74](/filings/0001030894-26-000032.md) | [1.82](/filings/0001030894-26-000044.md) | [2.31](/filings/0001030894-26-000050.md) | not reported | [1.83](/filings/0001030894-26-000032.md) | [3.17](/filings/0001030894-26-000044.md) | [3.26](/filings/0001030894-26-000050.md) |
| Free cash flow | $m | [95.8 d](/filings/0001030894-26-000011.md) | [93.6](/filings/0001030894-26-000032.md) | [120](/filings/0001030894-26-000044.md) | [88.9](/filings/0001030894-26-000050.md) | [156 d](/filings/0001030894-26-000011.md) | [127](/filings/0001030894-26-000032.md) | [147](/filings/0001030894-26-000044.md) | [116](/filings/0001030894-26-000050.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [5.6](/filings/0001030894-24-000009.md) | [7.3](/filings/0001030894-25-000014.md) | [8.0](/filings/0001030894-26-000011.md) | [9.6](/filings/0001030894-26-000011.md) | [12.4](/filings/0001030894-26-000011.md) |
| Gross margin | % | [8.6%](/filings/0001030894-24-000009.md) | [9.0%](/filings/0001030894-25-000014.md) | [9.5%](/filings/0001030894-26-000011.md) | [10.7%](/filings/0001030894-26-000011.md) | [12.1%](/filings/0001030894-26-000011.md) |
| Operating margin | % | [3.0%](/filings/0001030894-24-000009.md) | [4.0%](/filings/0001030894-25-000014.md) | [4.2%](/filings/0001030894-26-000011.md) | [6.2%](/filings/0001030894-26-000011.md) | [8.4%](/filings/0001030894-26-000011.md) |
| Net margin | % | [1.8%](/filings/0001030894-24-000009.md) | [2.5%](/filings/0001030894-25-000014.md) | [3.1%](/filings/0001030894-26-000011.md) | [4.4%](/filings/0001030894-26-000011.md) | [6.7%](/filings/0001030894-26-000011.md) |
| Diluted EPS | $ per share | [0.82](/filings/0001030894-24-000009.md) | [1.46](/filings/0001030894-25-000014.md) | [2.03](/filings/0001030894-26-000011.md) | [3.61](/filings/0001030894-26-000011.md) | [7.16](/filings/0001030894-26-000011.md) |
| Free cash flow | $bn | not reported | [0.1](/filings/0001030894-25-000014.md) | [0.2](/filings/0001030894-26-000011.md) | [0.3](/filings/0001030894-26-000011.md) | [0.5](/filings/0001030894-26-000011.md) |

- Revenue. XBRL Revenue: ifrs-full:RevenueFromContractsWithCustomers; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: ifrs-full:GrossProfit; Revenue: ifrs-full:RevenueFromContractsWithCustomers; Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: ifrs-full:ProfitLossFromOperatingActivities; Revenue: ifrs-full:RevenueFromContractsWithCustomers; Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: ifrs-full:ProfitLossAttributableToOwnersOfParent; Revenue: ifrs-full:RevenueFromContractsWithCustomers; Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: ifrs-full:DilutedEarningsLossPerShare; Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: ifrs-full:CashFlowsFromUsedInOperatingActivities; Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cls/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $3.08bn | 8,446,912 |  | Added +886,587 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $1.33bn | 3,874,584 |  | Reduced −576,209 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.16bn | 3,187,470 |  | Added +30,905 |
| [FRANKLIN RESOURCES INC](/funds/38777.md) | 2026-06-30 | $1.01bn | 2,777,601 |  | Added +133,878 |
| [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $766.4m | 2,100,985 |  | Reduced −432,030 |
| [CIBC WORLD MARKET INC.](/funds/1421224.md) | 2026-06-30 | $757.8m | 2,079,718 |  | Reduced −22,858 |
| [D. E. Shaw & Co., Inc.](/funds/1009207.md) | 2026-06-30 | $684.3m | 1,876,165 |  | Added +881,280 |
| [Connor, Clark & Lunn Investment Management Ltd.](/funds/1596800.md) | 2026-06-30 | $674.2m | 1,846,032 |  | Added +176,779 |
| [Value Aligned Research Advisors, LLC](/funds/1963565.md) | 2026-06-30 | $575.1m | 1,576,402 |  | Added +84,908 |
| [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $554.9m | 1,521,260 |  | Reduced −669,153 |

## Recent filings

[All 700 filings](/companies/cls/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 07:17 ET | [8-K](/filings/0001104659-26-118978.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-118978 |
| 2026-10-26 | 16:26 ET | [10-Q](/filings/0001030894-26-000050.md) | Quarterly report, period 2026-09-30 | 0001030894-26-000050 |
| 2026-10-26 | 16:23 ET | [8-K](/filings/0001030894-26-000049.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001030894-26-000049 |
| 2026-09-11 | 16:22 ET | [8-K](/filings/0001104659-26-107079.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-107079 |
| 2026-08-07 | 16:01 ET | [8-K](/filings/0001104659-26-092676.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-092676 |
| 2026-07-27 | 16:47 ET | [10-Q](/filings/0001030894-26-000044.md) | Quarterly report, period 2026-06-30 | 0001030894-26-000044 |
| 2026-07-27 | 16:44 ET | [8-K](/filings/0001030894-26-000043.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001030894-26-000043 |
| 2026-07-06 | 16:29 ET | [8-K](/filings/0001030894-26-000038.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001030894-26-000038 |
| 2026-05-19 | 16:21 ET | [8-K](/filings/0001030894-26-000035.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001030894-26-000035 |
| 2026-04-28 | 08:02 ET | [8-K](/filings/0001104659-26-049818.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-26-049818 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001030894-26-000011.md), filed Feb 27, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/18efba69-5646-403a-8fcd-acb111734a4d)

## About the filer

- CIK: 1030894
- Tickers: CLS
- Exchange: NYSE
- SIC code: 3672 Printed Circuit Boards
- State of incorporation: A6
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 07:19 ET. No prices; not investment advice.